Europe scrambles as J&J vaccine delay deals another blow

BARCELONA, Spain (AP) — European nations are scrambling in the wake of Johnson & Johnson’s delay of the rollout of its COVID-19 vaccines amid reports of very rare blood clots. Some leaders opted for caution Wednesday after American health officials paused the vaccine’s use while they study the clots in a handful of people. Experts agree COVID-19 poses a much larger risk of death and hospitalization than the potential threat of atypical clots. Italy, Croatia and Denmark put